Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation
- Stephen Bent
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Herbal products have gained increasing popularity in the last decade, and are now used by approximately 20% of the population. Herbal products are complex mixtures of organic chemicals that may come from any raw or processed part of a plant, including leaves, stems, flowers, roots, and seeds. Under the current law, herbs are defined as dietary supplements, and manufacturers can therefore produce, sell, and market herbs without first demonstrating safety and efficacy, as is required for pharmaceutical drugs. Although herbs are often perceived as “natural” and therefore safe, many different side effects have been reported owing to active ingredients, contaminants, or interactions with drugs.
Unfortunately, there is limited scientific evidence to establish the safety and efficacy of most herbal products. Of the top 10 herbs, 5 (ginkgo, garlic, St. John’s wort, soy, and kava) have scientific evidence suggesting efficacy, but concerns over safety and a consideration of other medical therapies may temper the decision to use these products.
Herbal products are not likely to become an important alternative to standard medical therapies unless there are changes to the regulation, standardization, and funding for research of these products.
- Barnes PM , Powell-Griner E , McFann K , Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;343:1–19.
- Swerdlow JL. Modern Science Embraces Medicinal Plants. Nature’s Medicine: Plants that Heal. Washington, DC: National Geographic Society; 2000:110–57.
- Swerdlow JL. Medicine Changes: late 19th to early 20th century. Nature’s Medicine: Plants that Heal. Washington, D.C.: National Geographic Society; 2000:158–91.
- Barrett B , Kiefer D , Rabago D. Assessing the risks and benefits of herbal medicine: an overview of scientific evidence. Altern Ther Health Med. 1999;5:40–9.
- Rotblatt M , Ziment I. Evidence-based herbal medicine. Philadelphia, PA: Hanley & Belfus; 2002.
- Dubber MJ , Kanfer I. High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms. J Pharm Pharm Sci. 2004;7:303–9.
- Institute of Medicine, National Academies Press. Dietary Supplements: A Framework for Evaluating Safety. Washington, DC: National Academies Press; 2005.
- Harkey MR , Henderson GL , Gershwin ME , Stern JS , Hackman RM. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr. 2001;73:1101–6. Jun.
- Linde K, Barrett B, Wolkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2006(1):CD000530.
- Turner RB , Bauer R , Woelkart K , Hulsey TC , Gangemi JD. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med. 2005;353:341–8. CrossRef
- Blumenthal M , Farnsworth NR. Echinacea angustifolia in rhinovirus infections. N Engl J Med. 2005;353:1971–2. CrossRef
- Vogler BK , Pittler MH , Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol. 1999;55:567–75. CrossRef
- Oken BS , Storzbach DM , Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol. 1998;55:1409–15. CrossRef
- Solomon PR , Adams F , Silver A , Zimmer J , DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA. 2002;288:835–40. CrossRef
- Pittler MH , Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med. 2000;108:276–81. CrossRef
- Birks J, Grimley EV, Van Dongen M. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2002(4):CD003120.
- Bent S , Goldberg H , Padula A , Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. J Gen Intern Med. 2005;20:657–61. CrossRef
- Stevinson C , Pittler MH , Ernst E. Garlic for treating hypercholesterolemia; a meta-analysis of randomized clinical trials. Ann Intern Med. 2000;133:420–9.
- Koren MJ. Statin use in a “real-world” clinical setting: aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trial. Am J Med. 2005;118Suppl 12A16–21. CrossRef
- Burnham BE. Garlic as a possible risk for postoperative bleeding. Plast Reconstr Surg. 1995;95:213. CrossRef
- Rose KD , Croissant PD , Parliament CF , Levin MB. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery. 1990;26:880–2. CrossRef
- Linde K, Mulrow CD, Berner M, Egger M. St John’s wort for depression. Cochrane Database Syst Rev. 2005(2):CD000448.
- Linde K , Ramirez G , Mulrow CD , Pauls A , Weidenhammer W , Melchart D. St John’s wort for depression—an overview and meta-analysis of randomised clinical trials. BMJ. 1996;313:253–8.
- Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St John’s wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002;287:1807–14. CrossRef
- Shelton RC , Keller MB , Gelenberg A , et al.. Effectiveness of St John’s wort in major depression: a randomized controlled trial. JAMA. 2001;285:1978–86. CrossRef
- Hammerness P , Basch E , Ulbricht C , et al.. St John’s wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics. 2003;44:271–82. CrossRef
- Pittler MH , Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Am J Gastroenterol. 1998;93:1131–5. CrossRef
- Ernst E , Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth. 2000;84:367–71.
- Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev. 2007(4):CD001395.
- Taku K , Umegaki K , Sato Y , Taki Y , Endoh K , Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2007;85:1148–56.
- Ulbricht C , Basch E. Natural standard herb and supplement reference: evidence-based clinical reviews. St. Louis, MO: Elsevier Mosby; 2005.
- Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database Syst Rev. 2003(1):CD003383.
- Centers for Disease Control and Prevention. Hepatic toxicity possibly associated with kava-containing products—United States, Germany, and Switzerland, 1999–2002. MMWR Morb Mortal Wkly Rep. 2002;51:1065–7.
- Winslow LC , Kroll DJ. Herbs as medicines. Arch Intern Med. 1998;158:2192–9. CrossRef
- Ernst E. Harmless herbs? A review of the recent literature. Am J Med. 1998;104:170–8. CrossRef
- Bent S , Ko R. Commonly used herbal medicines in the United States: a review. Am J Med. 2004;116:478–85. CrossRef
- De Smet PA. Herbal remedies. N Engl J Med. 2002;347:2046–56. CrossRef
- Nortier JL , Martinez MC , Schmeiser HH , et al.. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342:1686–92. CrossRef
- Stickel F , Patsenker E , Schuppan D. Herbal hepatotoxicity. J Hepatol. 2005;43:901–10. CrossRef
- Ko RJ. Adulterants in Asian patent medicines. N Engl J Med. 1998;339:847. CrossRef
- Ang-Lee MK , Moss J , Yuan CS. Herbal medicines and perioperative care. JAMA. 2001;286:208–16. CrossRef
- Bent S , Tiedt TN , Odden MC , Shlipak MG. The relative safety of ephedra compared with other herbal products. Ann Intern Med. 2003;138:468–71.
- Shekelle PG , Hardy ML , Morton SC , et al.. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA. 2003;289:1537–45. CrossRef
- DHHS, FDA. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule. Fed Regist. 2004;69:6787–6854.
- Hoffman BB , Taylor P. Neurotransmission. In: Hardman JG, Limbird LE, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 10New York, NY: McGraw-Hill; 2001:115–53.
- Haller CA , Benowitz NL , Jacob P 3rd. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med. 2005;118:998–1003. CrossRef
- DHHS. Adverse event reporting for dietary supplements: An inadequate safety valve. US:: Office of the Inspector General, HHS.; 2001.
- Bent S , Padula A , Neuhaus J. Safety and efficacy of citrus aurantium for weight loss. Am J Cardiol. 2004;94:1359–61. CrossRef
- Colker C , Kalman D , Torina G , Perlis T , Street C. Effects of Citrus aurantium extract, caffeine, and St. John’s Wort on body fat loss, lipid levels, and mood states in overweight healthy adults. Curr Ther Res. 1999;60:145–53. CrossRef
- Miracleburn with Hoodia and Advantra-Z! http://miracleburn.com/productinfo.htm. Accessed March 26, 2008.
- Morris CA , Avorn J. Internet marketing of herbal products. JAMA. 2003;290:1505–9. CrossRef
- Blendon RJ , DesRoches CM , Benson JM , Brodie M , Altman DE. Americans’ views on the use and regulation of dietary supplements. Arch Intern Med. 2001;161:805–10. CrossRef
- Eisenberg DM , Davis RB , Ettner SL , et al.. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998;280:1569–75. CrossRef
- Lewis JD , Strom BL. Balancing safety of dietary supplements with the free market. Ann Intern Med. 2002;136:616–8.
- Marcus DM , Grollman AP. Botanical medicines—the need for new regulations. N Engl J Med. 2002;347:2073–6. CrossRef
- Jacobs BP , Bent S , Tice JA , Blackwell T , Cummings SR. An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. Medicine (Baltimore). 2005;84:197–207. CrossRef
- Fugh-Berman A. The 5-Minute Herb & Dietary Supplement Consult. Philadelphia, PA: Lippincott Williams & Wilkins; 2003.
- Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation
Journal of General Internal Medicine
Volume 23, Issue 6 , pp 854-859
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- herbal medicine
- Industry Sectors
- Stephen Bent (1) (2) (3) (4)
- Author Affiliations
- 1. Osher Center for Integrative Medicine, University of California, San Francisco, CA, USA
- 2. Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA
- 3. Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
- 4. San Francisco VAMC, San Francisco, CA, USA